Suicidality Over the First 5 Years of Psychosis: Does Extending Early Intervention Have Benefits?

RCT depressive symptoms early intervention first-episode psychosis longitudinal course suicidality

Journal

Canadian journal of psychiatry. Revue canadienne de psychiatrie
ISSN: 1497-0015
Titre abrégé: Can J Psychiatry
Pays: United States
ID NLM: 7904187

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 29 9 2020
medline: 21 10 2021
entrez: 28 9 2020
Statut: ppublish

Résumé

We aimed to investigate whether individuals with first-episode psychosis (FEP) receiving extended early intervention (EI) were less likely to experience suicidal ideation and behaviors than those transferred to regular care after 2 years of EI. Another objective was to examine the 5-year course of suicidality in FEP. We conducted a secondary analysis of a randomized controlled trial where 220 patients were randomized after 2 years of EI to receive extended EI or regular care for the subsequent 3 years. Suicidality was rated using the Brief Psychiatric Rating Scale. Linear mixed model analysis was used to study time and group effects on suicidality. Extended EI and regular care groups did not differ on suicidality. There was a small decrease in suicidality over time, The first month of treatment is a critical period for suicide risk in FEP. Although early reductions in suicidality are often maintained, our findings make the case for sustained monitoring for suicide risk management.

Identifiants

pubmed: 32986470
doi: 10.1177/0706743720961714
pmc: PMC8107949
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

468-476

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH093303
Pays : United States
Organisme : CIHR
ID : MCT 94189
Pays : Canada

Références

Schizophr Res. 1990 Jul-Aug;3(4):247-51
pubmed: 2278986
Schizophr Res. 2010 Jan;116(1):1-8
pubmed: 19864115
Br J Psychiatry. 2017 Dec;211(6):350-358
pubmed: 28982659
Early Interv Psychiatry. 2008 Feb;2(1):11-21
pubmed: 21352126
Eur Neuropsychopharmacol. 2015 Dec;25(12):2278-88
pubmed: 26475577
Int J Soc Psychiatry. 2012 Jan;58(1):41-6
pubmed: 20826497
Br J Psychiatry. 2015 Jun;206(6):492-500
pubmed: 25657355
J Nerv Ment Dis. 2015 May;203(5):356-64
pubmed: 25900548
Am J Psychiatry. 2018 May 1;175(5):443-452
pubmed: 29495897
BMC Psychiatry. 2015 Feb 14;15:22
pubmed: 25881022
PLoS One. 2013;8(1):e55176
pubmed: 23372832
Psychol Med. 2004 Feb;34(2):255-66
pubmed: 14982131
Br J Psychiatry Suppl. 2007 Dec;51:s140-6
pubmed: 18055932
Schizophr Res. 2010 Nov;123(2-3):257-62
pubmed: 20685083
Acta Psychiatr Scand. 2004 Feb;109(2):116-20
pubmed: 14725592
Br J Psychiatry. 2013 May;202(5):372-80
pubmed: 23520223
Schizophr Res. 2014 Aug;157(1-3):12-8
pubmed: 24976591
Schizophr Res. 2020 Aug;222:382-388
pubmed: 32507375
Psychol Med. 2018 Apr;48(5):765-776
pubmed: 28805179
Suicide Life Threat Behav. 2019 Apr;49(2):423-431
pubmed: 29444349
BMJ. 2004 Jul 31;329(7460):261
pubmed: 15213108
Arch Gen Psychiatry. 2010 Dec;67(12):1230-7
pubmed: 21135323
Psychiatry Res. 2010 Jan 30;175(1-2):98-103
pubmed: 19962766
Schizophr Res. 2018 Dec;202:347-353
pubmed: 29935885
Front Psychiatry. 2016 Jun 27;7:116
pubmed: 27445872
BMJ. 2017 Jan 12;356:i6681
pubmed: 28082379
Br J Psychiatry Suppl. 2002 Sep;43:s98-106
pubmed: 12271808
Schizophr Bull. 1998;24(4):629-34
pubmed: 9853794
Arch Gen Psychiatry. 2005 Mar;62(3):247-53
pubmed: 15753237
Am J Psychiatry. 2005 Mar;162(3):441-9
pubmed: 15741458
World Psychiatry. 2017 Oct;16(3):278-286
pubmed: 28941098
JAMA Psychiatry. 2018 May 1;75(5):458-464
pubmed: 29617517
Lancet Psychiatry. 2016 May;3(5):443-50
pubmed: 26948484

Auteurs

Srividya N Iyer (SN)

Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
Prevention and Early Intervention Program for Psychosis (PEPP), 26632Douglas Mental Health University Institute, Montreal, Quebec, Canada.

Sally S Mustafa (SS)

Prevention and Early Intervention Program for Psychosis (PEPP), 26632Douglas Mental Health University Institute, Montreal, Quebec, Canada.

Laura Moro (L)

Prevention and Early Intervention Program for Psychosis (PEPP), 26632Douglas Mental Health University Institute, Montreal, Quebec, Canada.
Department of Psychiatry, 5622University of Montreal, Montreal, Quebec, Canada.

G Eric Jarvis (GE)

Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
First Episode Psychosis Program (FEPP), 5621Jewish General Hospital, Montreal, Quebec, Canada.

Ridha Joober (R)

Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
Prevention and Early Intervention Program for Psychosis (PEPP), 26632Douglas Mental Health University Institute, Montreal, Quebec, Canada.

Sherezad Abadi (S)

26632Douglas Mental Health University Institute, Montreal, Quebec, Canada.

Nicola Casacalenda (N)

Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
First Episode Psychosis Program (FEPP), 5621Jewish General Hospital, Montreal, Quebec, Canada.

Howard C Margolese (HC)

Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
Prevention and Early Intervention Program for Psychosis (PEPP-MUHC), 5620McGill University Health Centre, Montreal, Quebec, Canada.

Amal Abdel-Baki (A)

Department of Psychiatry, 5622University of Montreal, Montreal, Quebec, Canada.

Martin Lepage (M)

Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
Prevention and Early Intervention Program for Psychosis (PEPP), 26632Douglas Mental Health University Institute, Montreal, Quebec, Canada.

Ashok Malla (A)

Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
Prevention and Early Intervention Program for Psychosis (PEPP), 26632Douglas Mental Health University Institute, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH